China: Panacea joins Dell to sponsor Orion Biotech SPAC in US$200m IPO

MSD Partners, the Dell family investment firm, and Chinese venture capital firm, Panacea, have sponsored Orion Biotech Opportunities Corp, a special purpose acquisition company (SPAC), which has raised US$200m with an IPO on Nasdaq. The offering consisted of 20 million units at US$10 per unit. The company was established by co-founders, James Huang, Orion’s CEO, and Chrystyna…

You must be a HMI Subscriber to view this content.

Subscribe Now »